Transforming Discovery into Opportunity

CDRD is a proud sponsor and regional host of the Sanofi Biogenius Canada competition for high school students. It’s critical that we all support science education!

Results from CDRD project with UBC researcher Dr. Kelly McNagny published in Breast Cancer Research.

Inhibiting podocalyxin, a specific protein associated with aggressive, hard-to-treat tumours slows down their ability to spread to other sites in the body.

CDRD has partnered with the MS Society to accelerate preclinical development of novel therapies for Multiple Sclerosis (MS).

We are seeking pre-proposals from academic investigators for collaborative projects… .

Karimah Es Sabar and Jason Crawford, CDRD welcomed Cathy McLeod, MP and Parliamentary Secretary to the Minister of Health and Minister of Western Economic Diversification.

Find out how CDRD and CDRD Ventures can now support Canadian Health Sciences Companies…..

Read more about our Opportunities for Industry……

UBC Pharmaceutical Sciences Building, home of The Centre for Drug Research and Development and CDRD Ventures Inc.


  • Over 1,000 early-stage technologies evaluated for commercial potential
  • Over 200 projects on 134 distinct technologies
  • 56 technologies advanced toward commercialization and/or commercialized
  • 4 spin-off companies launched
  • 5  technologies out-licensed

“”My transition from a postdoctoral fellow to an associate scientist position truly exemplifies CDRD’s mandate to train and develop the next generation of highly qualified young professionals in drug development research.”
- Dr.Pauline So, Associate Scientist, Target Validation

Our latest Trainee Spotlight focuses on Dr. Jayakumar Surendradoss, our current Post-Doctoral Fellow in our Pharmacology/Toxicology Division.  Click here to find out more about him.

New Federal Funding Enables CDRD and CDRD Ventures Inc. to Expand Support to Canadian Entrepreneurs…

….Read more 

What is CDRD?

The Centre for Drug Research and Development (CDRD) is Canada’s fully-integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Our mandate is to de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector — thus successfully bridging the commercialization gap between academia and industry, and translating research discoveries into new therapies for patients. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).

NEW: Find our how CDRD and CVI can now support Canadian health sciences companies…..


Latest from the Blog

Persevere and turn a challenge into an opportunity

CDRD proud to participate in first meeting of Global Translational Research Collaborators hosted by NIH’s National Centre for Advancing Translational Sciences (NCATS).


Latest from Twitter


A Shared Vision

  • Industry
  • Academia
  • Government

Sign up to our newsletter

Receive CDRD’s and CVI's quarterly e-newsletter, The CDRD Pipeline and other e-communications for regular updates on all our news and activities.

© Copyright 2015 CDRD. All rights reserved.